TRIPEP

Serial Number 75723830
606

Registration Progress

Application Filed
Jun 7, 1999
Under Examination
Mar 13, 2001
Approved for Publication
Nov 17, 2000
Published for Opposition
Dec 19, 2000
Registered

Trademark Image

TRIPEP

Basic Information

Serial Number
75723830
Filing Date
June 7, 1999
Published for Opposition
December 19, 2000
Abandonment Date
March 14, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 14, 2003
Classes
005

Rights Holder

TRIPEP AB

03
Address
Rontgenvagen 3
SE-141 52 Huddinge
SE

Ownership History

TRIPEP AB

Original Applicant
03
SE-141 52 Huddinge SE

TRIPEP AB

Owner at Publication
03
SE-141 52 Huddinge SE

Legal Representation

Attorney
AnneMarie Kaiser

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Nov 5, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 17, 2002 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 26, 2002 MAIL I PAPER RECEIVED Loading...
Aug 26, 2002 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 1, 2002 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 29, 2002 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 11, 2002 MAIL I PAPER RECEIVED Loading...
Mar 8, 2002 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 10, 2001 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 23, 2001 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 13, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 19, 2000 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 17, 2000 NPUB O NOTICE OF PUBLICATION Loading...
Jul 27, 2000 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 17, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 17, 1999 CNRT F NON-FINAL ACTION MAILED Loading...
Sep 14, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
FULL LINE OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF VARIOUS DISEASES, NAMELY HIV AND OTHER VIRAL DISEASES, CANCER, INFECTIOUS DISEASES, INFLAMMATORY DISEASES, ALZHEIMER'S DISEASE, PRION DISEASE, AND TO MODULATE IMMUNE RESPONSE
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005